“The U.S. Food and Drug Administration (FDA) has authorized a new COVID-19 vaccine from Novavax, giving Americans an alternative to shots from Moderna and Pfizer. Novavax’s protein-based vaccine will be available soon after regulators granted emergency authorization to the Maryland-based company for the product. FDA officials said that animal testing data supported the decision…Critics say that the agency should not be making an assertion about safety and effectiveness in the absence of clinical trial data.”
FDA Authorizes New COVID-19 Vaccine Without Clinical Data | The Epoch Times